Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002285
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
A Phase III Pilot Trial To Evaluate Zidovudine AZT and T Lymphocyte Transfer in the Treatment of Human Immunodeficiency Virus Type-III HIV Infection in AIDS Patients
Status:
COMPLETED
Status Verified Date:
1995-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the safety and efficacy of zidovudine AZT treatment combined with syngeneic or HLA identical allogeneic lymphocyte transfer in the presence of interleukin 2 IL-2 as a treatment for AIDS Patients with documented HIV viremia will be evaluated Effects on virus replication immune function and clinical condition will be monitored with periodic virus cultures estimates of lymphocyte type and numbers cell surface markers in vitro lymphocyte responses and frequent clinical evaluations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 27433-10 | None | None | None |